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INTRODUCTION
Glioblastoma multiforme (GBM) is a lethal brain tumor, with most patients dying within one year of diagnosis (1, 2). The last decade has witnessed very little advance in treatment, but the identification of stem-like cancer cells in brain tumors has provided new insights into the disease. Several groups have identified a sub-population of stemlike, cancer cells in brain tumors, using biomarker analysis and culturing techniques similar to those used to characterize normal neural stem cells. These cells demonstrate a significant tumor-initiating ability, are capable of self-renewal, and express neural stem cell markers, such as Nestin and CD133, but not markers of the differentiated neural lineage (3-7). Although these cells represent only a small fraction of the tumor bulk, their high self-renewal capacity is thought to sustain tumor growth. The identification of signaling pathways that maintain the proliferative capacity of these cells and/or regulate their decision to differentiate offers great potential for a better understanding of the disease at the molecular level.
For neural stem cells, the decision to divide or differentiate is strongly influenced by Wnt signaling, while other factors, such as EGF and FGF, stimulate their proliferation (8-10). Wnt ligands are capable of activating several distinct signal transduction pathways and promoting a large spectrum of cellular processes, such as proliferation, differentiation, polarity, adhesion and migration (11, 12) . Wnt signaling pathways are usually categorized as canonical, or non-canonical. The former describes the classical ȕ-catenin/gene transcription pathway, while the latter is most often linked with polarity establishment and cytoskeleton-mediated processes, but can also involve gene transcriptional effects (though not through ȕ-catenin). The scaffold protein Dishevelled Ͷ (Dvl) plays an essential role in all known Wnt signaling pathways. Activation of canonical Wnt signaling recruits Dvl to the plasma membrane, resulting in the disassembly of the ß-catenin destruction complex and leading to the translocation of active ß-catenin to the nucleus, with subsequent activation of gene expression.
Activation of non-canonical Wnt pathways leads to Dvl-mediated activation of Rho GTPases, planar cell polarity proteins, and Ca
2+
-dependent signals (13) (14) (15) (16) (17) . In order to discriminate between canonical or non-canonical pathways, Wnt signaling utilizes different domains of Dvl to activate distinct downstream components. In particular, the DIX domain is responsible for binding to Axin and activation of the canonical/ȕ-catenin pathway, while the DEP domain functions only in the non-canonical Wnt pathway and is responsible for activation of the small GTPases, Rho and Rac (18) .
Mutations in the genes encoding components of Wnt signaling pathways have been found in many human cancers, notably colorectal cancer (13, 19) . Mutations in axin, ȕ-catenin and APC are found in sporadic medulloblastomas along with nuclear localization of ȕ-catenin, suggesting constitutive Wnt signaling (20) (21) (22) . Wnt signaling through the canonical β-catenin pathway has also been reported to increase the stemlike behavior of astrocytes and glioma cell lines, while downregulation of canonical Wnt/ β-catenin pathway induces apoptosis in glioma cell lines (23, 24) . High expression levels of Dvl2 have so far been observed in both lung and colon cancer. Dvl overexpression has been shown to be critical for Wnt signaling in non-small cell lung cancer (25, 26) . Dvl has also been implicated, together with mTOR, in the progression of colorectal neoplasia (27).
ͷ In this study, we examine the role of Dvl in human gliomas. A tissue microarray analysis revealed Dvl2 overexpression in more than 70% of the analyzed GBM samples. Dvl2 depletion was found to block the proliferation of human gliomas and promote their differentiation both in vitro and in vivo. Finally, both canonical and noncanonical signaling pathways are required to maintain the proliferative capacity of glioma cells.
MATHERIALS AND METHODS
Animal experiments
Cells were infected with viral vectors and selected in puromycin as described below. 6-8 weeks old NOD/SCID female mice were stereotactically injected with 2x10 5 cells into the striatum under a Memorial Sloan-Kettering Animal Care Committee-approved protocol. The animals were imaged using Magnetic Resonance Imaging (MRI) at MSKCC animal imaging core facility. Mice were maintained until development of neurologic signs and then sacrificed and perfusion-fixed with 4% para-formaldehyde (PFA). The brains were post-fixed for 24h in 4% PFA, incubated in 30% sucrose and then snap frozen in Optimal Cutting Temperature (OCT) compound and cut on a cryostat (coronal sections, 25μM). Standard protocols were used for Hematoxylin-Eosin staining. Immunofluorescence staining was performed as described in the section "Immunofluorescence staining". 
Tissue microarray and tumor samples
Cell lines and human GBMs
The human glioma cell lines U87, U138, U373 and U251 were cultured in MEM GlutaMax (Gibco, 41090) supplemented with 10% FCS, 10mM Hepes, non-essential amino acids (Gibco, 11140) and antibiotics. LN229 were cultured in DME supplemented with 5% FCS and antibiotics. Primary glioblastoma samples were derived form patients undergoing surgery at Memorial Sloan-Kettering Cancer Center. Primary GBM samples were dissociated as described by Pollard and colleagues and grown as a monolayer on plastic cell culture dishes coated with 10ng/ml laminin (Sigma, L2020) (28 October 11, 2011; DOI: 10.1158 /0008-5472.CAN-11-1531 ͳͲ
RESULTS
Endogenous Dishevelled is expressed at high levels in human glioblastomas
Overexpression of Dvl has been shown to potentiate the activation of Wnt signaling pathways (29, 30) . To examine the potential role of Wnt signaling in high-grade brain tumors, we first compared the expression levels of Dvl2 (the most widely expressed isoform of Dishevelled) in normal and cancer brain tissues using the Oncomine database. Analysis based on a set of data including 80 glioblastoma samples showed that the levels of Dvl2 mRNA were increased in brain cancer tissue compared to normal tissue ( Figure 1A ) (31). The Cancer Genome Atlas (TCGA) data set was also analyzed for Dvl2 expression in brain cancer but the results appeared not significant (P=1.000; not shown). The level of Dvl2 protein was next analyzed in a group of 10, freshly-derived GBM samples. As shown in Figure 1B , Dvl2 is overexpressed, though to different extents, in all patient samples, when compared to normal brain tissue. EGF receptor (EGFR) overexpression and p53 loss are commonly found in human GBMs, but no significant correlation was found between Dvl2 and either EGFR or p53 expression ( Figure 1B) (2, 32, 33) . We also analyzed the status of isocitrate dehydrogenase-1 (IDH1) gene in these freshly-derived samples (34). As shown in supplementary Fig.1 , only one sample showed a mutation in IDH1, the mutation being the less common R132G.
To further investigate the expression levels of Dvl2 in high-grade gliomas, a tissue microarray (TMA) containing 35 samples from patients diagnosed with grade IV glioma and 5 control brain samples was examined using a Dvl2-specific antibody. Author Manuscript Published OnlineFirst on October 11, 2011; DOI: 10.1158/0008-5472. CAN-11-1531 ͳͳ Tumors were scored as negative (0), medium positive (1), or very positive (2). Dvl2 is overexpressed in more than 70% of the GBM samples, with around 20% of these showing very high levels ( Figure 1C ). We conclude that Dvl2 is overexpressed in a significant number of human GBM samples, raising the possibility that Wnt signaling plays an important role in these tumors.
Dishevelled depletion blocks proliferation and induces differentiation of U87 glioma cells
To explore the role of Wnt signaling in human GBM, lentiviral shRNA vectors targeting Dvl2, which is essential for all known Wnt signaling pathways, were obtained (14). The glioma cell line U87, originally derived from a human glioblastoma, harbors mutations in PTEN and p16 ink4a , and is highly proliferative and tumorigenic both in vivo and in vitro. Two different lentiviral constructs, which efficiently deplete Dvl2 in these cells significantly inhibited their proliferation (Figure 2A ,B). This was associated with an increase in the cell cycle inhibitor p21 WAF ( Figure 2B ), a decrease in BrdU incorporation ( Figure 2C ) and inhibition of anchorage independent growth (Supplemental Figure 2A ,B). The proliferation block associated with Dvl2 depletion was not accompanied by apoptotic death or senescence (Supplemental Figure 3A ,B).
Time-lapse video microscopy ( Figure 2D Since differentiation of stem/progenitor cells is associated with the loss of self-renewal, the impact of Dvl2 depletion on neurosphere formation was examined. The formation of non-adherent neurospheres, in serum-free media supplemented with EGF and FGF, is a widely recognized property of neural stem cells and is commonly used as an in vitro surrogate for self-renewal or stem cell-like properties (35). U87 cells efficiently form neurospheres after 10d of culture in neural stem cell medium, but this is dramatically reduced after Dvl2 depletion ( Figure 2G -H). These data indicate that Dvl2 is necessary for the proliferation of U87 glioma cells and that Wnt signaling pathways have a role in regulating the neurosphere forming ability of these cells.
To confirm the specificity of RNAi depletion, rescue experiments were performed using a mouse Dvl2 (mDvl2) construct that is resistant to the sh2 lentivirus. A partial rescue of the proliferation defect and associated downregulation of p21 WAF was observed ( Figure 3A,C) . In addition, a partial rescue of differentiation was observed, with increased Nestin expression and decreased Tuj1 expression ( Figure 3A ,B).
Consistent with these findings, overexpressing of Dvl2 in U87 cells resulted in an increase in Nestin expression levels together with an increase in proliferation and neurosphere formation (Supplemental Figure 6A -C). 
ͳ͵
To explore the wider significance of Dvl2 in human glioblastoma, four additional cell lines, U373, U138, LN229 and U251, each carrying different genetic mutations were infected with an shRNA lentiviral vector (36). Dvl2 depletion inhibited the proliferation of all four lines in serum cultures and in anchorage independent growth assays (Supplemental Figure 7A,B) , while p21 WAF protein levels were increased in 3 of the 4 lines (Supplemental Figure 7C ).
Dishevelled depletion induces the differentiation of primary, patient-derived glioblastoma cultures.
To determine whether Dvl2 plays an important role in primary human glioblastoma (GBM), freshly derived tumor samples were obtained from three individual patients (GBM1/GBM2/GBM3) (Supplemental Table 1 Dvl2 depletion inhibited the proliferation of all three GBMs in serum cultures ( Figure   4 ), as well as their ability to grow as neurospheres in neural stem cell medium ( Figure   5H ). All three GBMs underwent significant morphological changes reminiscent of differentiation, together with down-regulation of Nestin and up-regulation of the glial marker GFAP (Figure 5A-G) . A significant increase in p21 WAF and Tuj1 was also seen by western blot in 2 out of 3 samples ( Figure 5G ). We conclude that Dvl2-mediated signaling is required to maintain the self-renewal ability of both glioma cell lines and patient-derived GBM samples. 
ͳͶ
Dishevelled depletion inhibits glioblastoma tumorigenicity in vivo.
To determine whether Dvl2 depletion is effective at suppressing in vivo tumorigenicity, intra-cranial injections of controls, or tumor cells originating from a patient tumor (GBM1), or cell lines (including a GFP-U87 line) expressing Dvl2 shRNA were performed in NOD/SCID mice (for a total of 8 control mice and 12 mice injected with Dvl2-depleted cells). Magnetic resonance imaging (MRI) performed 13 weeks after injection of cells derived from patient GBM1 revealed an extensive and invasive tumor mass ( Figure 6A ). However, GBM1 cells that had been infected with Dvl2 shRNA lentivirus 7d prior to intra-cranial injection did not produce tumors detectable by MRI or histology at this time ( Figure 6A ). In one out of 3 mice injected with Dvl2 depleted GBM1, a small lesion was detectable by MRI at 21 weeks after injection (not shown; the animal was left alive for 25 weeks). Overall, the absence of tumor mass was reflected in the survival curve, indicating that Dishevelled signaling is critical for glioma development in vivo ( Figure 6F ). To investigate the fate of Dvl2-depleted GBM1 cells in vivo, brain cryo-sections were obtained. Immunohistological studies showed a highly proliferative tumor mass in mice injected with control, but not Dvl2-depleted cells ( Figure 6B) . Similarly, using an antibody specific for human Nestin, rare human GBM1 cells were found at the Dvl2 depleted injection sites ( Figure 6C ). The small lesion found in one out of 12 mice injected with Dvl2-depleted cells, was positive for human Nestin (not shown). 2011; DOI: 10.1158 /0008-5472.CAN-11-1531 ͳͷ To determine whether Dvl2-depleted cells die after injection, or adopt a differentiated phenotype and integrate into the mouse brain, a GFP-expressing U87 cell line (U87-GFP) was generated. Control cells (U87-GFP) generated a tumor 5 weeks after intracranial injection, while Dvl2-depleted U87-GFP cells induced no lesions detectable by MRI up to 20 weeks after injection ( Figure 6G , Supplemental Figure 8A ,B).
Subsequent analysis of brain cryo-sections for GFAP (an astrocytic differentiation marker) and GFP, revealed cells that had infiltrated the mouse brain and were positive for both ( Figure 6D ,E, arrows). This result indicates that the injected Dvl2 depleted cells are still present in the mouse brain, and some adopt a differentiate-like state ( Figure 6D ,E). 2011; DOI: 10.1158 /0008-5472.CAN-11-1531 2011; DOI: 10.1158 /0008-5472.CAN-11-1531 Scores (0), (1) and (2) 
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